PNC Financial Services Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $85.3K | Buy |
|
|||||
|
2025
Q2 | $40.1K | Sell |
|
|||||
|
2025
Q1 | $44.6K | Buy |
|
|||||
|
2024
Q4 | $60.9K | Sell |
|
|||||
|
2024
Q3 | $346K | Buy |
|
|||||
|
2024
Q2 | $365K | Buy |
|
|||||
|
2024
Q1 | $439K | Buy |
|
|||||
|
2023
Q4 | $322K | Buy |
|
|||||
|
2023
Q3 | $108K | Sell |
|
|||||
|
2023
Q2 | $154K | Buy |
|
|||||
|
2023
Q1 | $131K | Sell |
|
|||||
|
2022
Q4 | $123K | Buy |
|
|||||
|
2022
Q3 | $198K | Sell |
|
|||||
|
2022
Q2 | $181K | Sell |
|
|||||
|
2022
Q1 | $549K | Sell |
|
|||||
|
2021
Q4 | $1.69M | Sell |
|
|||||
|
2021
Q3 | $2.39M | Sell |
|
|||||
|
2021
Q2 | $3.01M | Buy |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|
|||||
|
2020
Q4 | $998K | Buy |
|
|||||
|
2020
Q3 | $266K | Buy |
|
|||||
|
2020
Q2 | $266K | Sell |
|
|||||
|
2020
Q1 | $278K | Buy |
|
|||||
|
2019
Q4 | $294K | Buy |
|
|||||
|
2019
Q3 | $120K | Sell |
|
|||||
|
2019
Q2 | $164K | Sell |
|
|||||
|
2019
Q1 | $179K | Buy |
|
|||||
|
2018
Q4 | $136K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $2K | Hold |
|
|||||
|
2017
Q2 | $2K | Hold |
|
|||||
|
2017
Q1 | $2K | Hold |
|
|||||
|
2016
Q4 | $2K | Hold |
|
|||||
|
2016
Q3 | $2K | Hold |
|
|||||
|
2016
Q2 | $2K | Buy |
|